What is Resilience?
Founded in 2021, Resilience is dedicated to enhancing the cancer treatment experience for both medical institutions and patients. The company aims to provide comprehensive support across all stages of treatment, leveraging technology to streamline processes and improve patient outcomes. Its focus on addressing critical needs within oncology care positions it as a key player in the health-tech landscape, seeking to bridge gaps in patient support and clinical efficiency.
How much funding has Resilience raised?
Resilience has raised a total of $70M across 2 funding rounds:
Series A
$45M
Other Financing Round
$25M
Series A (2022): $45M with participation from Singular, Fondation Santé Service, Macsf, Vivalto Ventures, Ramsay Santé, EXOR, Cathay Innovation, Picus Capital, and Seaya Ventures
Other Financing Round (2024): $25M led by Picus Capital and Red River West
Key Investors in Resilience
Picus Capital
Picus Capital is an early-stage technology investment firm that focuses on long-term investments in innovative technology companies, providing strategic insights and operational support.
Red River West
Red River West invests in outstanding European tech companies, providing significant financial support and expertise to facilitate their expansion into the U.S. market.
Singular
Singular is a marketing intelligence platform that transforms marketing data into actionable insights to drive growth to businesses.
What's next for Resilience?
With the recent influx of major strategic investment, Resilience is poised for significant expansion and development. The company is likely to focus on scaling its operations, enhancing its technological infrastructure, and broadening its reach within the healthcare ecosystem. This capital will enable Resilience to further its mission of supporting cancer treatment institutes and patients, potentially through new service offerings, strategic partnerships, or advancements in its core platform. The enterprise-level backing suggests a trajectory towards becoming a leader in patient-centric cancer care solutions.
See full Resilience company page
